Activity content starts in:

Industry Webcast

Treating MDD: A Rapid-Acting Oral Antidepressant With Multimodal ActivityIndustry Webcast Sponsored by Axsome Therapeutics, Inc.; Not for CME/CE Credit

This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD.

Register

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 11/19/2024

Expiration Date: 11/19/2024

Faculty

Faculty

Default Biography Avatar

Todd Broder, MD

Medical Director of Psychiatry, University of Florida Health Flagler Hospital
Co-Founder, Florida Center for Transcranial Magnetic Stimulation (TMS)
Board Certified in Adult & Forensic Psychiatry by The American Board of Psychiatry and Neurology

Learn More

Supporters and Partners

Industry Sponsor

Axsome Therapeutics, Inc.

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

Treating MDD: A Rapid-Acting Oral Antidepressant With Multimodal Activity

Register